Patents by Inventor Jonathan Rowe

Jonathan Rowe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same
    Patent number: 10493058
    Abstract: In various embodiments, the present invention provides compositions and methods for treating and/or preventing a cardiovascular-related disease in subject in need thereof.
    Type: Grant
    Filed: June 3, 2015
    Date of Patent: December 3, 2019
    Assignee: Amarin Pharmaceuticals Ireland Limited
    Inventor: Jonathan Rowe
  • Compositions comprising 15-HEPE and methods of treating or preventing fibrosis using same
    Patent number: 10363235
    Abstract: The present disclosure provides compositions comprising 15-HEPE and methods of using same for treating and/or preventing fibrosis in a subject in need thereof.
    Type: Grant
    Filed: March 7, 2016
    Date of Patent: July 30, 2019
    Assignee: Afimmune Limited
    Inventors: Jonathan Rowe, Kevin Duffy, John Climax
  • LOW ERUCTATION COMPOSITION AND METHODS FOR TREATING AND/OR PREVENTING CARDIOVASCULAR DISEASE IN A SUBJECT WITH FISH ALLERGY/HYPERSENSITIVITY
    Publication number: 20190175537
    Abstract: In various embodiments, the present invention provides pharmaceutical compositions comprising fatty acids and methods for treating subjects using same.
    Type: Application
    Filed: November 2, 2018
    Publication date: June 13, 2019
    Inventors: Ian Osterloh, Pierre Wicker, Rene Braeckman, Paresh Soni, Jonathan Rowe
  • COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING CARDIOVASCULAR DISEASE
    Publication number: 20170128406
    Abstract: In various embodiments, the present invention provides pharmaceutical compositions comprising fatty acids and methods for treating subjects using same.
    Type: Application
    Filed: January 23, 2017
    Publication date: May 11, 2017
    Inventor: Jonathan Rowe
  • COMPOSITIONS COMPRISING 15-HEPE AND METHODS OF TREATING OR PREVENTING FIBROSIS USING SAME
    Publication number: 20160184252
    Abstract: The present disclosure provides compositions comprising 15-HEPE and methods of using same for treating and/or preventing fibrosis in a subject in need thereof.
    Type: Application
    Filed: March 7, 2016
    Publication date: June 30, 2016
    Inventors: Jonathan Rowe, Kevin Duffy, John Climax
  • COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING CARDIOVASCULAR DISEASE
    Publication number: 20150335607
    Abstract: In various embodiments, the present invention provides pharmaceutical compositions comprising fatty acids and methods for treating subjects using same.
    Type: Application
    Filed: May 28, 2015
    Publication date: November 26, 2015
    Inventor: Jonathan Rowe
  • PHARMACEUTICAL COMPOSITIONS COMPRISING OMEGA-3 FATTY ACIDS
    Publication number: 20150272917
    Abstract: The present disclosure relates to, inter alia, pharmaceutical compositions comprising omega-3 fatty acids.
    Type: Application
    Filed: November 7, 2014
    Publication date: October 1, 2015
    Inventors: Mehar Manku, Jonathan Rowe
  • PHARMACEUTICAL COMPOSITION COMPRISING OMEGA-3 FATTY ACID AND HYDROXY-DERIVATIVE OF A STATIN AND METHODS OF USING SAME
    Publication number: 20150265574
    Abstract: In various embodiments, the present invention provides compositions and methods for treating and/or preventing a cardiovascular-related disease in subject in need thereof.
    Type: Application
    Filed: June 3, 2015
    Publication date: September 24, 2015
    Inventor: Jonathan Rowe
  • COMPOSITIONS COMPRISING 15-OHEPA AND METHODS OF USING THE SAME
    Publication number: 20150224076
    Abstract: The present invention relates to the compositions, formulations and methods of treating fatty liver disorders, such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) and their sequelae by administration of 15-OHEPA.
    Type: Application
    Filed: April 24, 2015
    Publication date: August 13, 2015
    Inventors: Jonathan Rowe, Kevin Duffy, John Climax
  • Compositions comprising 20-carbon fatty acids and methods of making and using same
    Patent number: 9096815
    Abstract: The present disclosure provides a process for producing 20-carbon fatty acids from a plant seed oil, the process comprising: a) providing a plant seed oil comprising fatty acids, wherein the fatty acids include 18-carbon fatty acids; and b) elongating the fatty acids by two carbon atoms to produce a composition comprising 20-carbon fatty acids.
    Type: Grant
    Filed: November 29, 2012
    Date of Patent: August 4, 2015
    Assignee: Dignity Sciences Limited
    Inventors: Mehar Manku, Jonathan Rowe, John Climax
  • PHARMACEUTICAL COMPOSITIONS COMPRISING DHA, EPA, AND/OR GLA AND AN ANTIBIOTIC AGENT AND METHODS OF USE THEREOF
    Publication number: 20150080329
    Abstract: The present disclosure provides compositions comprising fatty acids, or derivatives thereof (e.g., C1-C4 esters) including, for example, DHA, EPA and/or GLA, used in combination with one or more antibiotic agents for the treatment of disease and/or disorders such as a skin or ocular infection.
    Type: Application
    Filed: September 19, 2014
    Publication date: March 19, 2015
    Inventors: Mehar Manku, John Climax, Jonathan Rowe
  • ANTIMICROBIAL COMPOSITIONS COMPRISING DGLA AND NEOMYCIN SULFATE AND METHODS OF USE THEREOF
    Publication number: 20140171358
    Abstract: The present disclosure provides compositions comprising fatty acids, or derivatives thereof (e.g., C1-C4 esters) including, for example, DGLA, 15-OHEPA and/or 15-HETrE, used alone or in combination with one or more antibiotic agents for the treatment of disease and/or disorders such as a skin infection or wound healing.
    Type: Application
    Filed: February 21, 2014
    Publication date: June 19, 2014
    Applicant: Dignity Sciences Limited
    Inventors: Mehar Manku, John Climax, Jonathan Rowe, David Coughlan
  • COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING CARDIOVASCULAR DISEASE
    Publication number: 20140128464
    Abstract: In various embodiments, the present invention provides pharmaceutical compositions comprising fatty acids and methods for treating subjects using same.
    Type: Application
    Filed: August 28, 2013
    Publication date: May 8, 2014
    Applicant: AMARIN PHARMACEUTICALS IRELAND LIMITED
    Inventor: Jonathan Rowe
  • LOW ERUCTATION COMPOSITION AND METHODS FOR TREATING AND/OR PREVENTING CARDIOVASCULAR DISEASE IN A SUBJECT WITH FISH ALLERGY/HYPERSENSITIVITY
    Publication number: 20140127289
    Abstract: In various embodiments, the present invention provides pharmaceutical compositions comprising fatty acids and methods for treating subjects using same.
    Type: Application
    Filed: November 28, 2011
    Publication date: May 8, 2014
    Applicant: ARMARIN PHARMACEUTICALS IRELAND LIMITED
    Inventors: Ian Osterloh, Pierre Wicker, Rene Braeckman, Paresh Soni, Jonathan Rowe
  • PHARMACEUTICAL COMPOSITIONS COMPRISING EPA AND A CARDIOVASCULAR AGENT AND METHODS OF USING THE SAME
    Publication number: 20120302589
    Abstract: The present invention relates to, inter alia, pharmaceutical compositions comprising EPA and one or more cardiovascular agents, and to therapeutic methods for treating various diseases and disorders using the same.
    Type: Application
    Filed: March 12, 2012
    Publication date: November 29, 2012
    Applicant: Amarin Pharma, Inc.
    Inventors: Mehar Manku, Jonathan Rowe
  • ANTIMICROBIAL COMPOSITIONS COMPRISING 15-HETRE AND METHODS OF USE THEREOF
    Publication number: 20120264705
    Abstract: The present disclosure provides compositions comprising fatty acids, or derivatives thereof (e.g., C1-C4 esters) including, for example, DGLA, 15-OHEPA and/or 15-HETrE, used alone or in combination with one or more antibiotic agents for the treatment of disease and/or disorders such as a skin infection or wound healing.
    Type: Application
    Filed: May 23, 2012
    Publication date: October 18, 2012
    Applicant: DIGNITY SCIENCES LIMITED
    Inventors: Mehar Manku, John Climax, Jonathan Rowe, David Coughlan
  • PHARMACEUTICAL COMPOSITIONS COMPRISING EPA AND A CARDIOVASCULAR AGENT AND METHODS OF USING THE SAME
    Publication number: 20120172432
    Abstract: The present invention relates to, inter alia, pharmaceutical compositions comprising EPA and one or more cardiovascular agents, and to therapeutic methods for treating various diseases and disorders using the same.
    Type: Application
    Filed: March 13, 2012
    Publication date: July 5, 2012
    Applicant: AMARIN PHARMA, INC.
    Inventors: Mehar Manku, Jonathan Rowe
  • PHARMACEUTICAL COMPOSITIONS COMPRISING EPA AND A CARDIOVASCULAR AGENT AND METHODS OF USING THE SAME
    Publication number: 20120121698
    Abstract: The present invention relates to, inter alia, pharmaceutical compositions comprising EPA and one or more cardiovascular agents, and to therapeutic methods for treating various diseases and disorders using the same.
    Type: Application
    Filed: April 29, 2010
    Publication date: May 17, 2012
    Applicant: AMARIN PHARMA, INC.
    Inventors: Mehar Manku, Jonathan Rowe
  • PHARMACEUTICAL COMPOSITIONS COMPRISING EPA AND A CARDIOVASCULAR AGENT AND METHODS OF USING THE SAME
    Publication number: 20120093922
    Abstract: The present invention relates to, inter alia, pharmaceutical compositions comprising EPA and one or more cardiovascular agents, and to therapeutic methods for treating various diseases and disorders using the same.
    Type: Application
    Filed: April 29, 2010
    Publication date: April 19, 2012
    Applicant: AMARIN CORPORATION PLC
    Inventors: Mehar Manku, Jonathan Rowe
  • COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING CARDIOVASCULAR DISEASE
    Publication number: 20110218243
    Abstract: In various embodiments, the present invention provides pharmaceutical compositions comprising fatty acids and methods for treating subjects using same.
    Type: Application
    Filed: March 4, 2011
    Publication date: September 8, 2011
    Applicant: Amarin Pharma, Inc.
    Inventor: Jonathan Rowe